C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/04 (2006.01) C07H 21/04 (2006.01) C07K 14/245 (2006.01) C07K 14/31 (2006.01) C12N 1/12 (2006.01) C12N 1/14 (2006.01) C12N 1/20 (2006.01) C12N 9/06 (2006.01) C12N 9/10 (2006.01) C12N 9/24 (2006.01) C12N 9/78 (2006.01) C12N 9/90 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01) C12Q 1/00 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2325602
Methods and compositions for screening compounds for potential therapeutic activity and for identifying drug targets are provided. The methods rely on controlled expression (either underexpression or overexpression) of an essential cellular gene, which can be achieved, in one embodiment, by fusion of a heterologous regulatory element to the gene. The method is capable of identifying a drug target in the absence of any knowledge of target function.
L'invention porte sur des méthodes et compositions servant au criblage de composés pour ce qui est de leur activité thérapeutique potentielle et à l'identification de cibles de médicaments. Lesdites méthodes, qui reposent sur l'expression régulée (sous ou sur expression) d'un gène essentiel de culture, laquelle dans l'une des variantes s'obtient par la fusion avec le gène d'un élément régulateur hétérologue, permettent d'identifier des cibles de médicaments même sans en connaître aucune des fonctions.
Rosenow Carsten
Trias Joaquim
Young Dennis
Gowling Lafleur Henderson Llp
Versicor Inc.
LandOfFree
Regulated target expression for screening does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated target expression for screening, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated target expression for screening will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2052295